BAVA:CPH
Bavarian Nordic A/S
DKK 216.80
arrow_downward
-1.90%(-4.20) 1H
1 Okt, 5:00:00 PTG GMT+2 · DKK
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk BAVA...
Buka
DKK 220.00
Tinggi
DKK 220.40
Rendah
DKK 216.20
Permodalan Pasaran
17.52B
Purata volum
225.46K
Volum
114.74K
tgi 52 mgu
DKK 243.70
rdh 52 mgu
DKK 171.30
Syer tertunggak
79.27J
Bilangan pekerja
2K
Buka
DKK 220.00
Tinggi
DKK 220.40
Rendah
DKK 216.20
Permodalan Pasaran
17.52B
Purata volum
225.46K
Volum
114.74K
tgi 52 mgu
DKK 243.70
rdh 52 mgu
DKK 171.30
Syer tertunggak
79.27J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
10 jam lalu
VOO dan SPY: 3 pemangkin utama untuk ETF S&P 500 pada Oktober
Fox Business
·
1 jam lalu
October could be a huge month for the stock market. Here's why.
Simply Wall Street
·
10 minit lalu
Why Is F5 (FFIV) Back As An IDC MarketScape Leader?
GuruFocus
·
11 minit lalu
Corteva (CTVA) Completes Spin-Off of Vylor, Leading to S&P 500 I
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Perihal Bavarian Nordic A/S